Public Health England is launching a review into “growing problem” of prescription drug addiction. The review, which will take a year, will cover: sedatives and anti-anxiety drugs known as benzodiazepines and z-drugs (zolpidem and zopiclone) painkillers called opioids, pre
What is the IASP Global Year of Excellence in Pain Education, and how does pain management research benefit the patient? This edition is funded by Pain Concern’s donors and friends, assisted by an educational grant from Grünenthal. The International Association for the Study of Pain (
In honour of the British Pain Society reaching a 50-year milestone, current BPS president Dr Andrew Baranowski, founding member Professor Sir Michael Bond, and Pain Concern’s chair Heather Wallace were invited to discuss a wide variety of topics relating to the understanding of pain.
We at Pain Concern wish to address the recent articles published in Pulse Today titled ‘Pregabalin and gabapentine set to become controlled drugs’ on the 21st September, and the British Medical Journal (BMJ) on the 25th September 2017 titled ‘UK government to reclassify pregabalin and
Pain Concern is a national charity that supports those who live with long term pain, and those who care for them, by providing information on pain and its management through a variety of media platforms. We also raise awareness about pain and the need to improve the provision of pain
Pain Concern supports the following press release from the Royal College of Anaesthetists and the Faculty of Pain Medicine “Response to recent news reports regarding fentanyl “The Royal College of Anaesthetists (RCoA) and The Faculty of Pain Medicine (FPM) are concerned with misinfor